|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Stock based compensation | |||||
| Stock-based compensation | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest income | |||||
| Interest expense | |||||
| Operating sublease income | |||||
| Loss on foreign exchange changes | |||||
| Loss on investment in equity securities | |||||
| Loss on impairment of equity investment | |||||
| Write off unclaimed accrued liabilities | |||||
| Other (loss) income, net | |||||
| Total other (expenses) | |||||
| Loss before provision for income tax | |||||
| Provision for income tax expense (benefit) | |||||
| Net loss | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net loss attributed to ABVC and subsidiaries | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Net loss per share: | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...